Stock Information
Charles River Laboratories International Inc (CRL)
Ticker Symbol: CRL
Exchange: NYSE
Sector: Life Sciences Tools & Services
Market Cap: $8,558.08 mil
Piotroski score: 5
PE Ratio: N/A
EPS (TTM): -2.9563
Revenue (TTM): $81.59 M
Dividend Yield: N/A%
ROE: -4.4%
Latest News
-
Charles River Laboratories Schedules First-Quarter 2026 Earnings Release and Conference Call
Thu, Apr 16, 2026 12:00 PM
-
Why Charles River (CRL) Is Up 5.8% After Divesting Units And Refreshing Its Leadership Team
Wed, Apr 15, 2026 8:12 PM
-
Will Charles River (CRL) Beat Estimates Again in Its Next Earnings Report?
Tue, Apr 14, 2026 4:10 PM
-
Tesla upgraded, AppLovin initiated: Wall Street's top analyst calls
Tue, Apr 14, 2026 1:53 PM
-
ValuEngine Weekly Market Summary And Commentary
Tue, Apr 14, 2026 10:30 AM
-
JP Morgan Maintains Neutral on Charles River, Lowers Price Target to $160
Mon, Apr 13, 2026 3:46 PM
-
Charles River Laboratories International (CRL) Positioned to Benefit from Preclinical Research Activity and Biotech Funding Recovery
Fri, Apr 10, 2026 1:24 PM
Key Financials
Financial data not available
